MEG3 and ovarian carcinoma: Third, further mechanistic studies are needed to delineate the precise apoptotic and cell cycle signaling pathways under MEG3 control in ovarian cancer, as well as to map the microRNA and epigenetic networks that mediate its influence on metastasis.